MedTrace Logo

A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice

NCT00505388 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5137

Last updated 2020-01-18

No results posted yet for this study

Summary

This patient follow-up programme was designed to describe the extent of Symbicort use in patients prescribed Symbicort as maintenance and reliever therapy in routine clinical practice in comparison with the already documented use of Symbicort as maintenance and reliever therapy in clinical therapies

Conditions

  • Bronchial Asthma

Sponsors & Collaborators

Principal Investigators

  • Tomas Andersson, MD · AstraZeneca

  • Bjorn Stallberg, MD · Trosa Vardcentral

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • Belgium
  • Bulgaria
  • Czechia
  • Denmark
  • Germany
  • Greece
  • Hungary
  • Netherlands
  • Norway
  • Portugal
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00505388 on ClinicalTrials.gov